glp-1 agonists weight loss side effects Clinical Recommendations to Manage Gastrointestinal Adverse Events in Patients Treated with Receptor Agonists: A Multidisciplinary Expert Consensus Struggling with GLP-1 therapy side

This article delves into key considerations and challenges health insurers face in the evolving landscape of approval and reimbursement for GLP-1s

Importantly, most subjects with exenatide-induced volume contraction were receiving drugs that inhibit the renin-angiotensin system and aldosterone formation

2023;doi:10.1056/NEJMoa2301972

Funnel plots performed for outcomes retrieved in at least 10 studies ruled out the possibility of publication bias (Figures S14, S16, S18, S20, S22, S24, S26)

Diabetes, vol

Which differentiating factors will enable specific companies and drugs to capture this market (and potentially $100B in upside)